AXNX – axonics, inc. (US:NASDAQ)

News

Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Axonics Reports First Quarter 2024 Financial Results
Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash [Seeking Alpha]
FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal [Reuters]
FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com